•
Sep 30, 2017

Jazz Pharmaceuticals Q3 2017 Earnings Report

Total Revenue
$412M
Previous year: $374M
+10.1%
EPS
$3.22
Previous year: $2.57
+25.3%
Gross Profit
$381M
Previous year: $350M
+8.8%
Cash and Equivalents
$253M
Previous year: $367M
-31.1%
Total Assets
$5B
Previous year: $4.93B
+1.4%

Jazz Pharmaceuticals

Jazz Pharmaceuticals